Trial Profile
A study of tocilizumab in patients with large vessel vasculitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant cell arteritis
- Focus Therapeutic Use
- 24 Oct 2018 Interim results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 04 Feb 2016 New trial record